scPharmaceuticals Inc. — Director's Dealing 2021

Jan 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: scPharmaceuticals Inc. (SCPH)
CIK: 0001604950
Period of Report: 2021-01-25

Reporting Person: Tucker John H (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-25	Stock Option (Right to Buy)	$7.06	A	112050	Acquired	2031-01-25	Common Stock (112050)	Direct

Footnotes

F1: The option shares vest over a four-year period, at a rate of 25% on the first anniversary of the grant date, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares are fully vested on the fourth anniversary of the grant date.